Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Levim Biotech LLP develops and commercializes biopharmaceuticals for acute diseases, oncology, and metabolic disorders. Their pipeline includes a biosimilar liraglutide injection that has completed a Phase 1 clinical trial comparing pharmacokinetics to Victoza® in healthy adults. The company leverages recombinant technology, macromolecule conjugation, antibody/protein engineering, gene therapy approaches, and advanced drug delivery systems. They also offer cGMP contract manufacturing services for preclinical/clinical supplies with regulatory capabilities[4][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Levima.